Basic Stats
| LEI | 549300U24SP4AF2JUX52 |
| CIK | 1069899 |
SEC Filings
All companies that sell securities in the United States must register with the Securities and Exchange Commission (SEC) and file reports on a regular basis.
These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus. This page shows recent SEC filings related to Phibro Animal Health Corporation
SEC Filings (Chronological Order)
This page provides a complete, chronological list of SEC Filings, excluding ownership filings which we provide elsewhere.
| August 27, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): August 27, 2025 Phibro Animal Health Corporation (EXACT NAME OF REGISTRANT AS SPECIFIED IN CHARTER) Delaware 001-36410 13-1840497 (State or other jurisdiction of incorporation) (Commission File Number) (IRS Employer Identification No. |
|
| August 27, 2025 |
Exhibit 10.22 PHIBRO ANIMAL HEALTH CORPORATION 2008 INCENTIVE PLAN RESTRICTED STOCK UNIT AWARD AGREEMENT – CAPITAL GAIN AWARD THIS AGREEMENT (this “Agreement”), made as of this [] day of [], 2025 (the “Grant Date”), by and between Phibro Animal Health Corporation, a Delaware corporation (the “Company”), and [] (the “Grantee”), sets forth the terms and conditions of an Award granted to the Grantee |
|
| August 27, 2025 |
[The Awards and the securities granted under the Phibro Animal Health Corporation 2008 Incentive Plan (the “Plan”) have not been and will not be publicly issued, placed, distributed, offered or negotiated in the Brazilian capital markets and, as a result, will not be registered with the Brazilian Securities Commission (Comissão de Valores Mobiliários) (“CVM”). |
|
| August 27, 2025 |
Exhibit 99.1 For Immediate Release Phibro Animal Health Corporation Reports Fourth Quarter and Fiscal Year Results, Provides Financial Guidance TEANECK, N.J., August 27, 2025 (Business Wire) – Phibro Animal Health Corporation (Nasdaq: PAHC) (“Phibro” or the “Company”) today announced financial results for its fourth quarter and fiscal year ended June 30, 2025 and provided its financial guidance fo |
|
| August 27, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended June 30, 2025 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-36410 |
|
| August 27, 2025 |
HEALTHY ANIMALS. HEALTHY FOOD. HEALTHY WORLD.® Glenpointe Centre East, 3rd Floor / 300 Frank W. Burr Blvd., Ste. 21 / Teaneck, NJ 07666-6712 Direct: 201-329-7300 / Fax: 201-329-7399 October 26, 2022 Judith Weinstein 345 East 81st Street Apt. 12J New York, NY 10028 Dear Judy: In recognition of your significant contributions for more than 14 years to Phibro Animal Health Corporation, a Delaware corp |
|
| August 27, 2025 |
PHIBRO ANIMAL HEALTH CORPORATION LIST OF SUBSIDIARIES EXHIBIT 21.1 PHIBRO ANIMAL HEALTH CORPORATION LIST OF SUBSIDIARIES SUBSIDIARY JURISDICTION 8861 Dice Road LLC California First Dice Road Company, A California Limited Partnership California Western Magnesium Corp. California Phibro Animal Health Holdings, Inc. Delaware Phibro-Tech, Inc. Delaware PhibroWood, LLC Delaware Prince Agri Products, Inc. Delaware PMC Quincy, Inc. Illinois C P Chemicals, I |
|
| July 29, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): July 29, 2025 Phibro Animal Health Corporation (EXACT NAME OF REGISTRANT AS SPECIFIED IN CHARTER) Delaware 01-36410 13-1840497 (State or other jurisdiction of incorporation) (Commission File Number) (IRS Employer Identification No. |
|
| July 29, 2025 |
Phibro Animal Health Corporation Declares Quarterly Dividend Exhibit 99.1 For Immediate Release Phibro Animal Health Corporation Declares Quarterly Dividend TEANECK, N.J., July 29, 2025 (Business Wire) – The Board of Directors of Phibro Animal Health Corporation (Nasdaq:PAHC) today declared a quarterly cash dividend of $0.12 per share on its Class A common stock and Class B common stock, payable on September 24, 2025, to stockholders of record at the close |
|
| May 7, 2025 |
Phibro Animal Health Corporation Reports Third Quarter Results, Updates Financial Guidance Exhibit 99.1 For Immediate Release Phibro Animal Health Corporation Reports Third Quarter Results, Updates Financial Guidance TEANECK, N.J., May 7, 2025 (Business Wire) – Phibro Animal Health Corporation (Nasdaq: PAHC) (“Phibro” or the “Company”) today announced financial results for its third quarter ended March 31, 2025, and its updated financial guidance for the year ending June 30, 2025. Highl |
|
| May 7, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): May 7, 2025 Phibro Animal Health Corporation (EXACT NAME OF REGISTRANT AS SPECIFIED IN CHARTER) Delaware 001-36410 13-1840497 (State or other jurisdiction of incorporation) (Commission File Number) (IRS Employer Identification No. |
|
| May 7, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2025 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 0 |
|
| May 6, 2025 |
Phibro Animal Health Corporation Declares Quarterly Dividend Exhibit 99.1 For Immediate Release Phibro Animal Health Corporation Declares Quarterly Dividend TEANECK, N.J., May 6, 2025 (Business Wire) – The Board of Directors of Phibro Animal Health Corporation (Nasdaq:PAHC) today declared a quarterly cash dividend of $0.12 per share on its Class A common stock and Class B common stock, payable on June 25, 2025, to stockholders of record at the close of busi |
|
| May 6, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): May 6, 2025 Phibro Animal Health Corporation (EXACT NAME OF REGISTRANT AS SPECIFIED IN CHARTER) Delaware 01-36410 13-1840497 (State or other jurisdiction of incorporation) (Commission File Number) (IRS Employer Identification No. |
|
| February 5, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended December 31, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number |
|
| February 5, 2025 |
Phibro Animal Health Corporation Reports Second Quarter Results, Updates Financial Guidance Exhibit 99.1 For Immediate Release Phibro Animal Health Corporation Reports Second Quarter Results, Updates Financial Guidance TEANECK, N.J., February 5, 2025 (Business Wire) – Phibro Animal Health Corporation (Nasdaq: PAHC) (“Phibro” or the “Company”) today announced financial results for its second quarter ended December 31, 2024, and its updated financial guidance for the year ending June 30, 2 |
|
| February 5, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): February 5, 2025 Phibro Animal Health Corporation (EXACT NAME OF REGISTRANT AS SPECIFIED IN CHARTER) Delaware 001-36410 13-1840497 (State or other jurisdiction of incorporation) (Commission File Number) (IRS Employer Identification No. |
|
| February 4, 2025 |
Phibro Animal Health Corporation Declares Quarterly Dividend Exhibit 99.1 For Immediate Release Phibro Animal Health Corporation Declares Quarterly Dividend TEANECK, N.J., February 4, 2025 (Business Wire) – The Board of Directors of Phibro Animal Health Corporation (Nasdaq:PAHC) today declared a quarterly cash dividend of $0.12 per share on its Class A common stock and Class B common stock, payable on March 26, 2025, to stockholders of record at the close o |
|
| February 4, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): February 4, 2025 Phibro Animal Health Corporation (EXACT NAME OF REGISTRANT AS SPECIFIED IN CHARTER) Delaware 01-36410 13-1840497 (State or other jurisdiction of incorporation) (Commission File Number) (IRS Employer Identification No. |
|
| January 23, 2025 |
Phibro Animal Health Corporation Announces the Appointment of Joyce J. Lee to Its Board of Directors Exhibit 99.1 For Immediate Release Phibro Animal Health Corporation Announces the Appointment of Joyce J. Lee to Its Board of Directors TEANECK, NJ, January 23, 2025 (Business Wire) - The Board of Directors of Phibro Animal Health Corporation (Nasdaq: PAHC) today announced the appointment of Joyce J. Lee, MBA, as a Class II director of the Company, effective immediately. Ms. Lee will be an indepen |
|
| January 23, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): January 23, 2025 (January 21, 2025) Phibro Animal Health Corporation (EXACT NAME OF REGISTRANT AS SPECIFIED IN CHARTER) Delaware 01-36410 13-1840497 (State or other jurisdiction of incorporation) (Commission File Number) (IRS Employer Identification No. |
|
| January 7, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K/A CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): October 31, 2024 Phibro Animal Health Corporation (EXACT NAME OF REGISTRANT AS SPECIFIED IN CHARTER) Delaware 001-36410 13-1840497 (State or other jurisdiction of incorporation) (Commission File Number) (IRS Employer Identification No. |
|
| January 7, 2025 |
UNAUDITED PRO FORMA CONDENSED COMBINED BALANCE SHEET Exhibit 99.3 UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL INFORMATION The following unaudited pro forma condensed combined financial information and notes thereto have been prepared by Phibro Animal Health Corporation (“Phibro” or the “Company”) in accordance with Article 11 of Regulation S-X in order to give effect to the Acquisition (as defined below). On April 28, 2024, Phibro and Phibro An |
|
| January 7, 2025 |
Exhibit 99.2 Medicated Feed Additives Product Portfolio of Zoetis Inc. Special Purpose Statements of Assets Acquired and Liabilities Assumed as of June 30, 2024 (Unaudited) and December 31, 2023 and Interim Special Purpose Statements of Revenue and Direct Expenses for the Six Months Ended June 30, 2024 (Unaudited) and June 30, 2023 (Unaudited) 1 Exhibit 99.2 Medicated Feed Additives Product Portfo |
|
| January 7, 2025 |
Exhibit 99.1 Medicated Feed Additives Product Portfolio of Zoetis Inc. Special Purpose Statements of Assets Acquired and Liabilities Assumed as of December 31, 2023 and December 31, 2022 and Special Purpose Statements of Revenue and Direct Expenses for the Years Ended December 31, 2023 and December 31, 2022 Exhibit 99.1 Independent Auditors’ Report The Board of Directors Zoetis Inc.: Opinion We ha |
|
| November 15, 2024 |
PAHC / Phibro Animal Health Corporation / BFI Co., LLC - SC 13D/A Activist Investment SC 13D/A 1 tm2428325d1sc13da.htm SC 13D/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D/A Under the Securities Exchange Act of 1934 (Amendment No. 21) Phibro Animal Health Corporation (Name of Issuer) Class A Common Stock, par value $0.0001 per share (Title of Class of Securities) 71742Q 106 (CUSIP Number) c/o Jack C. Bendheim Phibro Animal Health Corporation |
|
| November 12, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): November 12, 2024 (November 7, 2024) Phibro Animal Health Corporation (EXACT NAME OF REGISTRANT AS SPECIFIED IN CHARTER) Delaware 01-36410 13-1840497 (State or other jurisdiction of incorporation) (Commission File Number) (IRS Employer Identification No. |
|
| November 6, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): November 6, 2024 (November 5, 2024) Phibro Animal Health Corporation (EXACT NAME OF REGISTRANT AS SPECIFIED IN CHARTER) Delaware 001-36410 13-1840497 (State or other jurisdiction of incorporation) (Commission File Number) (IRS Employer Identification No. |
|
| November 6, 2024 |
Phibro Animal Health Corporation Reports First Quarter Results, Updates Financial Guidance Exhibit 99.1 For Immediate Release Phibro Animal Health Corporation Reports First Quarter Results, Updates Financial Guidance TEANECK, N.J., November 6, 2024 (Business Wire) – Phibro Animal Health Corporation (Nasdaq: PAHC) (“Phibro” or the “Company”) today announced financial results for its first quarter ended September 30, 2024 and its updated financial guidance for the year ending June 30, 202 |
|
| November 6, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Numbe |
|
| November 5, 2024 |
Phibro Animal Health Corporation Declares Quarterly Dividend Exhibit 99.1 For Immediate Release Phibro Animal Health Corporation Declares Quarterly Dividend TEANECK, N.J., November 5, 2024 (Business Wire) – The Board of Directors of Phibro Animal Health Corporation (Nasdaq:PAHC) today declared a quarterly cash dividend of $0.12 per share on its Class A common stock and Class B common stock, payable on December 18, 2024, to stockholders of record at the clos |
|
| November 5, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): November 5, 2024 Phibro Animal Health Corporation (EXACT NAME OF REGISTRANT AS SPECIFIED IN CHARTER) Delaware 001-36410 13-1840497 (State or other jurisdiction of incorporation) (Commission File Number) (IRS Employer Identification No. |
|
| October 31, 2024 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): October 31, 2024 Phibro Animal Health Corporation (EXACT NAME OF REGISTRANT AS SPECIFIED IN CHARTER) Delaware 001-36410 13-1840497 (State or other jurisdiction of incorporation) (Commission File Number) (IRS Employer Identification No. |
|
| October 31, 2024 |
Exhibit 99.1 Phibro Animal Health Corporation Completes Acquisition of Zoetis’ Medicated Feed Additive Product Portfolio and Certain Water-Soluble Products TEANECK, N.J. October 31, 2024 (Business Wire) - Phibro Animal Health Corporation (Nasdaq: PAHC) today announced the successful completion of the acquisition of the medicated feed additive product portfolio and certain water-soluble products fr |
|
| September 20, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☐ Defin |
|
| September 20, 2024 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule |
|
| August 28, 2024 |
Phibro Animal Health Corporation Clawback Policy. Exhibit 97.1 CLAWBACK POLICY PHIBRO ANIMAL HEALTH CORPORATION PURPOSE Phibro Animal Health Corporation (the “Company”) believes that it is in the best interests of the Company and its shareholders to create and maintain a culture that emphasizes integrity and accountability and that reinforces the Company’s pay-for-performance compensation philosophy. The Company’s Board of Directors (the “Board”) |
|
| August 28, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): August 28, 2024 Phibro Animal Health Corporation (EXACT NAME OF REGISTRANT AS SPECIFIED IN CHARTER) Delaware 001-36410 13-1840497 (State or other jurisdiction of incorporation) (Commission File Number) (IRS Employer Identification No. |
|
| August 28, 2024 |
Phibro Animal Health Corporation Insider Trading and Disclosure of Confidential Information Policy. Exhibit 19.1 INSIDER TRADING AND DISCLOSURE OF CONFIDENTIAL INFORMATION POLICY This Policy (the “Insider Trading Policy”) has been adopted by the Board of Directors of Phibro Animal Health Corporation, a Delaware corporation (the “Company”). In adopting this Insider Trading Policy, the Board is mindful that the Company has responsibilities to several constituencies and has various objectives and t |
|
| August 28, 2024 |
List of Subsidiaries of Phibro Animal Health Corporation. EXHIBIT 21.1 PHIBRO ANIMAL HEALTH CORPORATION LIST OF SUBSIDIARIES SUBSIDIARY JURISDICTION 8861 Dice Road LLC California First Dice Road Company, A California Limited Partnership California Western Magnesium Corp. California Phibro Animal Health Holdings, Inc. Delaware Prince Agri Products, Inc. Delaware Phibro-Tech, Inc. Delaware PhibroWood, LLC Delaware PMC Quincy, Inc. Illinois C P Chemicals, I |
|
| August 28, 2024 |
Exhibit 2.1 EXECUTION VERSION PURCHASE AND SALE AGREEMENT BY AND AMONG PHIBRO ANIMAL HEALTH CORPORATION, PHIBRO ANIMAL HEALTH S.A. AND ZOETIS INC. Dated as of April 28, 2024 TABLE OF CONTENTS Page ARTICLE I DEFINITIONS 1 Section 1.1 Definitions 1 Section 1.2 Other Defined Terms 15 ARTICLE II PURCHASE AND SALE; CLOSING 19 Section 2.1 Purchase and Sale 19 Section 2.2 Purchase Price 19 Section 2.3 Cl |
|
| August 28, 2024 |
Exhibit 99.1 For Immediate Release Phibro Animal Health Corporation Reports Fourth Quarter and Fiscal Year Results, Provides Financial Guidance TEANECK, N.J., August 28, 2024 (Business Wire) – Phibro Animal Health Corporation (Nasdaq: PAHC) (“Phibro” or the “Company”) today announced financial results for its fourth quarter and fiscal year ended June 30, 2024 and provided its financial guidance fo |
|
| August 28, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended June 30, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-36410 |
|
| August 28, 2024 |
Exhibit 10.25 October 10, 2023 Glenn David 3 Spring Hill Ln. Morristown, NJ 07960 Email: [email protected] Dear Glenn, I am pleased to present to you an offer of employment with Phibro Animal Health Corporation (the “Company”) as its Chief Financial Officer (CFO), reporting directly to me. Our offer to you is as follows: Start Date Your anticipated start date with the Company will be agreed upon by y |
|
| August 28, 2024 |
Exhibit 10.1 Execution Version STRICTLY CONFIDENTIAL COÖPERATIEVE RABOBANK U.A., NEW YORK BRANCH 245 Park Avenue New York, NY 10167 COMPEER FINANCIAL, PCA 2600 Jenny Wren Trail PO Box 810 Sun Prairie, Wisconsin 53590 CITIBANK, N.A. 388 Greenwich Street New York, New York 10013 CONFIDENTIAL April 28, 2024 Phibro Animal Health Corporation Glenpointe Centre East, 3rd Floor 300 Frank W. Burr Boulevard |
|
| July 30, 2024 |
Phibro Animal Health Corporation Declares Quarterly Dividend Exhibit 99.1 For Immediate Release Phibro Animal Health Corporation Declares Quarterly Dividend TEANECK, N.J., July 30, 2024 (Business Wire) – The Board of Directors of Phibro Animal Health Corporation (Nasdaq:PAHC) today declared a quarterly cash dividend of $0.12 per share on its Class A common stock and Class B common stock, payable on September 25, 2024, to stockholders of record at the close |
|
| July 30, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): July 30, 2024 Phibro Animal Health Corporation (EXACT NAME OF REGISTRANT AS SPECIFIED IN CHARTER) Delaware 01-36410 13-1840497 (State or other jurisdiction of incorporation) (Commission File Number) (IRS Employer Identification No. |
|
| July 9, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): July 9, 2024 Phibro Animal Health Corporation (EXACT NAME OF REGISTRANT AS SPECIFIED IN CHARTER) Delaware 001-36410 13-1840497 (State or other jurisdiction of incorporation) (Commission File Number) (IRS Employer Identification No. |
|
| July 9, 2024 |
Credit Agreement, dated July 3, 2024. Exhibit 10.1 Execution Version CREDIT AGREEMENT Dated as of July 3, 2024, among PHIBRO ANIMAL HEALTH CORPORATION, as the Borrower, COÖPERATIEVE RABOBANK U.A., NEW YORK BRANCH, as Administrative Agent, Collateral Agent and L/C Issuer, and THE LENDERS PARTY HERETO Arranged By: COÖPERATIEVE RABOBANK U.A., NEW YORK BRANCH, BOFA SECURITIES, INC., COMPEER FINANCIAL, PCA CITIBANK, N |
|
| May 8, 2024 |
Phibro Animal Health Corporation Reports Third Quarter Results, Updates Financial Guidance Exhibit 99.1 For Immediate Release Phibro Animal Health Corporation Reports Third Quarter Results, Updates Financial Guidance TEANECK, N.J., May 8, 2024 (Business Wire) – Phibro Animal Health Corporation (Nasdaq: PAHC) (“Phibro” or the “Company”) today announced financial results for its third quarter ended March 31, 2024 and its updated financial guidance for the year ending June 30, 2024. Highli |
|
| May 8, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 0 |
|
| May 8, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): May 8, 2024 Phibro Animal Health Corporation (EXACT NAME OF REGISTRANT AS SPECIFIED IN CHARTER) Delaware 001-36410 13-1840497 (State or other jurisdiction of incorporation) (Commission File Number) (IRS Employer Identification No. |
|
| May 7, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): May 7, 2024 Phibro Animal Health Corporation (EXACT NAME OF REGISTRANT AS SPECIFIED IN CHARTER) Delaware 01-36410 13-1840497 (State or other jurisdiction of incorporation) (Commission File Number) (IRS Employer Identification No. |
|
| May 7, 2024 |
Phibro Animal Health Corporation Declares Quarterly Dividend Exhibit 99.1 For Immediate Release Phibro Animal Health Corporation Declares Quarterly Dividend TEANECK, N.J., May 7, 2024 (Business Wire) – The Board of Directors of Phibro Animal Health Corporation (Nasdaq:PAHC) today declared a quarterly cash dividend of $0.12 per share on its Class A common stock and Class B common stock, payable on June 26, 2024, to stockholders of record at the close of busi |
|
| April 29, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): April 28, 2024 Phibro Animal Health Corporation (EXACT NAME OF REGISTRANT AS SPECIFIED IN CHARTER) Delaware 001-36410 13-1840497 (State or other jurisdiction of incorporation) (Commission File Number) (IRS Employer Identification No. |
|
| April 29, 2024 |
Zoetis to Sell Medicated Feed Additive Portfolio to Phibro Animal Health Exhibit 99.1 Zoetis to Sell Medicated Feed Additive Portfolio to Phibro Animal Health PARSIPPANY, NJ and TEANECK, NJ – April 28, 2024 – Zoetis Inc. (NYSE:ZTS) and Phibro Animal Health Corporation (Nasdaq: PAHC) today announced that they have entered into a definitive agreement where Phibro Animal Health will acquire Zoetis’ medicated feed additive (MFA) product portfolio, certain water soluble pro |
|
| February 14, 2024 |
PAHC / Phibro Animal Health Corporation / BFI Co., LLC - SC 13D/A Activist Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D/A Under the Securities Exchange Act of 1934 (Amendment No. 20) Phibro Animal Health Corporation (Name of Issuer) Class A Common Stock, par value $0.0001 per share (Title of Class of Securities) 71742Q 106 (CUSIP Number) c/o Jack C. Bendheim Phibro Animal Health Corporation Glenpointe Centre East, 3rd Fl. 300 Frank |
|
| February 13, 2024 |
PAHC / Phibro Animal Health Corporation / VANGUARD GROUP INC - SCHEDULE 13G/A Passive Investment SC 13G/A 1 tv01694-phibroanimalhealthco.htm SCHEDULE 13G/A SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 10)* Name of issuer: Phibro Animal Health Corporation Class A Title of Class of Securities: Common Stock CUSIP Number: 71742Q106 Date of Event Which Requires Filing of this Statement: December 29, 2023 Check the |
|
| February 8, 2024 |
SC 13G 1 phibroanimalhea13gde.htm SC 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 Phibro Animal Health Corp (Name of Issuer) COMMON STOCK (Title of Class of Securities) 71742Q106 (CUSIP Number) December 31, 2023 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rul |
|
| February 7, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): February 7, 2024 Phibro Animal Health Corporation (EXACT NAME OF REGISTRANT AS SPECIFIED IN CHARTER) Delaware 001-36410 13-1840497 (State or other jurisdiction of incorporation) (Commission File Number) (IRS Employer Identification No. |
|
| February 7, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended December 31, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number |
|
| February 7, 2024 |
Phibro Animal Health Corporation Reports Second Quarter Results, Updates Financial Guidance Exhibit 99.1 For Immediate Release Phibro Animal Health Corporation Reports Second Quarter Results, Updates Financial Guidance TEANECK, N.J., February 7, 2024 (Business Wire) – Phibro Animal Health Corporation (Nasdaq: PAHC) (“Phibro” or the “Company”) today announced financial results for its second quarter ended December 31, 2023 and its updated financial guidance for the year ending June 30, 20 |
|
| February 6, 2024 |
Phibro Animal Health Corporation Declares Quarterly Dividend Exhibit 99.1 For Immediate Release Phibro Animal Health Corporation Declares Quarterly Dividend TEANECK, N.J., February 6, 2024 (Business Wire) – The Board of Directors of Phibro Animal Health Corporation (Nasdaq:PAHC) today declared a quarterly cash dividend of $0.12 per share on its Class A common stock and Class B common stock, payable on March 27, 2024, to stockholders of record at the close o |
|
| February 6, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): February 6, 2024 Phibro Animal Health Corporation (EXACT NAME OF REGISTRANT AS SPECIFIED IN CHARTER) Delaware 001-36410 13-1840497 (State or other jurisdiction of incorporation) (Commission File Number) (IRS Employer Identification No. |
|
| February 6, 2024 |
Phibro Animal Health Corporation Announces Chief Financial Officer Changes Exhibit 99.1 For Immediate Release Phibro Animal Health Corporation Announces Chief Financial Officer Changes TEANECK, N.J., February 6, 2024 (Business Wire) – TEANECK, N.J., February 6, 2024 (Business Wire) – Phibro Animal Health Corporation (Nasdaq: PAHC) (the “Company” or “Phibro”) today announced that Glenn C. David has joined Phibro and will assume the role of Chief Financial Officer effectiv |
|
| February 6, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): February 6, 2024 Phibro Animal Health Corporation (EXACT NAME OF REGISTRANT AS SPECIFIED IN CHARTER) Delaware 001-36410 13-1840497 (State or other jurisdiction of incorporation) (Commission File Number) (IRS Employer Identification No. |
|
| November 8, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Numbe |
|
| November 8, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): November 8, 2023 Phibro Animal Health Corporation (EXACT NAME OF REGISTRANT AS SPECIFIED IN CHARTER) Delaware 001-36410 13-1840497 (State or other jurisdiction of incorporation) (Commission File Number) (IRS Employer Identification No. |
|
| November 8, 2023 |
Phibro Animal Health Corporation Reports First Quarter Results, Updates Financial Guidance Exhibit 99.1 For Immediate Release Phibro Animal Health Corporation Reports First Quarter Results, Updates Financial Guidance TEANECK, N.J., November 8, 2023 (Business Wire) – Phibro Animal Health Corporation (Nasdaq: PAHC) (“Phibro” or the “Company”) today announced financial results for its first quarter ended September 30, 2023 and its updated financial guidance for the year ending June 30, 202 |
|
| November 7, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): November 7, 2023 (November 6, 2023) Phibro Animal Health Corporation (EXACT NAME OF REGISTRANT AS SPECIFIED IN CHARTER) Delaware 001-36410 13-1840497 (State or other jurisdiction of incorporation) (Commission File Number) (IRS Employer Identification No. |
|
| November 7, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): November 7, 2023 Phibro Animal Health Corporation (EXACT NAME OF REGISTRANT AS SPECIFIED IN CHARTER) Delaware 01-36410 13-1840497 (State or other jurisdiction of incorporation) (Commission File Number) (IRS Employer Identification No. |
|
| November 7, 2023 |
Exhibit 99.1 For Immediate Release Phibro Animal Health Corporation Reiterates Safety of Mecadox® and Intent to Defend its Use for Customers TEANECK, NJ, November 7, 2023 (Business Wire) - (NASDAQ:PAHC) The Food and Drug Administration (FDA), through its Center for Veterinary Medicine (CVM), has taken two actions regarding Mecadox® (carbadox), a drug marketed by Phibro Animal Health Corporation. I |
|
| November 6, 2023 |
Phibro Animal Health Corporation Declares Quarterly Dividend Exhibit 99.1 For Immediate Release Phibro Animal Health Corporation Declares Quarterly Dividend TEANECK, N.J., November 6, 2023 (Business Wire) – The Board of Directors of Phibro Animal Health Corporation (Nasdaq:PAHC) today declared a quarterly cash dividend of $0.12 per share on its Class A common stock and Class B common stock, payable on December 20, 2023, to stockholders of record at the clos |
|
| November 6, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): November 6, 2023 Phibro Animal Health Corporation (EXACT NAME OF REGISTRANT AS SPECIFIED IN CHARTER) Delaware 001-36410 13-1840497 (State or other jurisdiction of incorporation) (Commission File Number) (IRS Employer Identification No. |
|
| September 15, 2023 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule |
|
| September 15, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☐ Defin |
|
| September 5, 2023 |
Phibro Animal Health Corporation Announces Chief Financial Officer Changes Exhibit 99.1 For Immediate Release Phibro Animal Health Corporation Announces Chief Financial Officer Changes TEANECK, N.J., September 5, 2023 (Business Wire) –Phibro Animal Health Corporation (Nasdaq:PAHC) (“Phibro” or the “Company”) today announced that Damian Finio, Phibro’s Chief Financial Officer, has informed the Company that he will resign from his position effective September 29, 2023. Phi |
|
| September 5, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): September 5, 2023 Phibro Animal Health Corporation (EXACT NAME OF REGISTRANT AS SPECIFIED IN CHARTER) Delaware 001-36410 13-1840497 (State or other jurisdiction of incorporation) (Commission File Number) (IRS Employer Identification No. |
|
| August 30, 2023 |
EXHIBIT 10.18 EXECUTIVE LONG-TERM INCENTIVE AGREEMENT This EXECUTIVE LONG-TERM INCENTIVE AGREEMENT (the “Agreement”) is made effective as of July 5, 2023 (the “Effective Date”) by and between Phibro Animal Health Corporation (the “Company”) and Larry L. Miller (the “Executive”). WHEREAS, the Executive presently serves as Chief Operating Officer, a senior executive of the Company; WHEREAS, the Comp |
|
| August 30, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): August 30, 2023 Phibro Animal Health Corporation (EXACT NAME OF REGISTRANT AS SPECIFIED IN CHARTER) Delaware 001-36410 13-1840497 (State or other jurisdiction of incorporation) (Commission File Number) (IRS Employer Identification No. |
|
| August 30, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended June 30, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-36410 |
|
| August 30, 2023 |
List of Subsidiaries of Phibro Animal Health Corporation. EXHIBIT 21.1 PHIBRO ANIMAL HEALTH CORPORATION LIST OF SUBSIDIARIES SUBSIDIARY JURISDICTION 8861 Dice Road LLC California First Dice Road Company, A California Limited Partnership California Western Magnesium Corp. California Phibro Animal Health Holdings, Inc. Delaware Prince Agri Products, Inc. Delaware Phibro-Tech, Inc. Delaware PhibroWood, LLC Delaware PMC Quincy, Inc. Delaware C P Chemicals, I |
|
| August 30, 2023 |
Exhibit 99.1 For Immediate Release Phibro Animal Health Corporation Reports Fourth Quarter and Fiscal Year Results, Provides Financial Guidance TEANECK, N.J., August 30, 2023 (Business Wire) – Phibro Animal Health Corporation (Nasdaq: PAHC) (“Phibro” or the “Company”) today announced financial results for its fourth quarter and fiscal year ended June 30, 2023 and provided guidance for the year end |
|
| July 25, 2023 |
Phibro Animal Health Corporation Declares Quarterly Dividend Exhibit 99.1 For Immediate Release Phibro Animal Health Corporation Declares Quarterly Dividend TEANECK, N.J., July 25, 2023 (Business Wire) – The Board of Directors of Phibro Animal Health Corporation (Nasdaq:PAHC) today declared a quarterly cash dividend of $0.12 per share on its Class A common stock and Class B common stock, payable on September 27, 2023, to stockholders of record at the close |
|
| July 25, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): July 25, 2023 Phibro Animal Health Corporation (EXACT NAME OF REGISTRANT AS SPECIFIED IN CHARTER) Delaware 001-36410 13-1840497 (State or other jurisdiction of incorporation) (Commission File Number) (IRS Employer Identification No. |
|
| July 6, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): July 5, 2023 Phibro Animal Health Corporation (EXACT NAME OF REGISTRANT AS SPECIFIED IN CHARTER) Delaware 01-36410 13-1840497 (State or other jurisdiction of incorporation) (Commission File Number) (IRS Employer Identification No. |
|
| June 16, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): June 16, 2023 Phibro Animal Health Corporation (EXACT NAME OF REGISTRANT AS SPECIFIED IN CHARTER) Delaware 01-36410 13-1840497 (State or other jurisdiction of incorporation) (Commission File Number) (IRS Employer Identification No. |
|
| June 16, 2023 |
Exhibit 10.1 Execution Version AMENDMENT NO. 2 This AMENDMENT NO. 2 (this “Agreement”), dated as of June 16, 2023, is among PHIBRO ANIMAL HEALTH CORPORATION, a Delaware corporation (the “Borrower”), each other Loan Party party hereto, BANK OF AMERICA, N.A. (“Bank of America”), as Administrative Agent, the 2023 Incremental Term Loan Lenders (as defined below) and the Consenting Lenders (as defined |
|
| June 8, 2023 |
PAHC / Phibro Animal Health Corp. - Class A / BFI Co., LLC - SC 13D/A Activist Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D/A Under the Securities Exchange Act of 1934 (Amendment No. 19) Phibro Animal Health Corporation (Name of Issuer) Class A Common Stock, par value $0.0001 per share (Title of Class of Securities) 71742Q 106 (CUSIP Number) c/o Jack C. Bendheim Phibro Animal Health Corporation Glenpointe Centre East, 3rd Fl. 300 Frank |
|
| May 3, 2023 |
Phibro Animal Health Corporation Reports Third Quarter and Year-to-Date Results Exhibit 99.1 For Immediate Release Phibro Animal Health Corporation Reports Third Quarter and Year-to-Date Results TEANECK, N.J., May 3, 2023 (Business Wire) – Phibro Animal Health Corporation (Nasdaq: PAHC) (“Phibro” or the “Company”) today announced financial results for its third quarter and year-to-date ended March 31, 2023. Highlights for the three months ended March 31, 2023 (compared to the |
|
| May 3, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): May 3, 2023 Phibro Animal Health Corporation (EXACT NAME OF REGISTRANT AS SPECIFIED IN CHARTER) Delaware 001-36410 13-1840497 (State or other jurisdiction of incorporation) (Commission File Number) (IRS Employer Identification No. |
|
| May 3, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 0 |
|
| May 1, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): May 1, 2023 Phibro Animal Health Corporation (EXACT NAME OF REGISTRANT AS SPECIFIED IN CHARTER) Delaware 001-36410 13-1840497 (State or other jurisdiction of incorporation) (Commission File Number) (IRS Employer Identification No. |
|
| May 1, 2023 |
Phibro Animal Health Corporation Declares Quarterly Dividend Exhibit 99.1 For Immediate Release Phibro Animal Health Corporation Declares Quarterly Dividend TEANECK, N.J., May 1, 2023 (Business Wire) – The Board of Directors of Phibro Animal Health Corporation (Nasdaq:PAHC) today declared a quarterly cash dividend of $0.12 per share on its Class A common stock and Class B common stock, payable on June 28, 2023, to stockholders of record at the close of busi |
|
| March 7, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G AMENDMENT NO 2 Under the Securities Exchange Act of 1934 PHIBRO ANIMAL HEALTH CORP (Name of Issuer) COMMON STOCK (Title of Class of Securities) 71742Q106 (CUSIP Number) February 28, 2023 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this S |
|
| February 9, 2023 |
PAHC / Phibro Animal Health Corp / VANGUARD GROUP INC - SCHEDULE 13G/A Passive Investment SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 9)* Name of issuer: Phibro Animal Health Corp. Class A Title of Class of Securities: Common Stock CUSIP Number: 71742Q106 Date of Event Which Requires Filing of this Statement: December 30, 2022 Check the appropriate box to designate the rule pursuant to which this Sched |
|
| February 8, 2023 |
Phibro Animal Health Corporation Reports Second Quarter Results Exhibit 99.1 For Immediate Release Phibro Animal Health Corporation Reports Second Quarter Results TEANECK, N.J., February 8, 2023 (Business Wire) – Phibro Animal Health Corporation (Nasdaq: PAHC) (“Phibro” or the “Company”) today announced financial results for its second quarter ended December 31, 2022. Highlights for the three months ended December 31, 2022 (compared to the three months ended D |
|
| February 8, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended December 31, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number |
|
| February 8, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): February 8, 2023 Phibro Animal Health Corporation (EXACT NAME OF REGISTRANT AS SPECIFIED IN CHARTER) Delaware 001-36410 13-1840497 (State or other jurisdiction of incorporation) (Commission File Number) (IRS Employer Identification No. |
|
| February 6, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): February 6, 2023 Phibro Animal Health Corporation (EXACT NAME OF REGISTRANT AS SPECIFIED IN CHARTER) Delaware 001-36410 13-1840497 (State or other jurisdiction of incorporation) (Commission File Number) (IRS Employer Identification No. |
|
| February 6, 2023 |
Exhibit 99.1 For Immediate Release Phibro Animal Health Corporation Announces the Appointment of Alejandro Bernal to Its Board of Directors and Declares Quarterly Dividend TEANECK, NJ, February 6, 2023 (Business Wire) - The Board of Directors of Phibro Animal Health Corporation (Nasdaq: PAHC) today announced the appointment of Alejandro Bernal, DVM, MS, MBA, as a Class III director of the Company, |
|
| January 20, 2023 |
PAHC / Phibro Animal Health Corp / PZENA INVESTMENT MANAGEMENT LLC - SC 13G/A Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G AMENDMENT NO 1 Under the Securities Exchange Act of 1934 PHIBRO ANIMAL HEALTH CORP (Name of Issuer) COMMON STOCK (Title of Class of Securities) 71742Q106 (CUSIP Number) December 31, 2022 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this S |
|
| December 16, 2022 |
PAHC / Phibro Animal Health Corp / BFI Co., LLC - SC 13D/A Activist Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D/A Under the Securities Exchange Act of 1934 (Amendment No. 18) Phibro Animal Health Corporation (Name of Issuer) Class A Common Stock, par value $0.0001 per share (Title of Class of Securities) 71742Q 106 (CUSIP Number) c/o Jack C. Bendheim Phibro Animal Health Corporation Glenpointe Centre East, 3rd Fl. 300 Frank |
|
| November 9, 2022 |
Phibro Animal Health Corporation Reports First Quarter Results, Revised Guidance ? Exhibit 99.1 ? ? ? ? For Immediate Release ? Phibro Animal Health Corporation Reports First Quarter Results, Revised Guidance ? TEANECK, N.J., November 9, 2022 (Business Wire) ? Phibro Animal Health Corporation (Nasdaq: PAHC) (?Phibro? or the ?Company?) today announced financial results for its first quarter ended September 30, 2022, and reiterated its financial guidance for Net sales and Adjust |
|
| November 9, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q Table of Contents ? ? UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| November 9, 2022 |
? ? UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 ? FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): November 9, 2022 Phibro Animal Health Corporation (EXACT NAME OF REGISTRANT AS SPECIFIED IN CHARTER) ? Delaware 001-36410 13-1840497 (State or other jurisdiction of incorporation) (Commission File Number) (IRS Employer Identification No. |
|
| November 9, 2022 |
Exhibit 10.1 ? EXECUTION VERSION ? AMENDMENT NO. 1 ? This AMENDMENT NO. 1 (this ?Agreement?), dated as of November 8, 2022, is among PHIBRO ANIMAL HEALTH CORPORATION, a Delaware corporation (the ?Borrower?), each other Loan Party party hereto, BANK OF AMERICA, N.A. (?Bank of America?), as Administrative Agent, Collateral Agent and L/C Issuer and each lender party hereto (collectively, the ?Lenders |
|
| November 8, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): November 8, 2022 (November 7, 2022) Phibro Animal Health Corporation (EXACT NAME OF REGISTRANT AS SPECIFIED IN CHARTER) Delaware 01-36410 13-1840497 (State or other jurisdiction of incorporation) (Commission File Number) (IRS Employer Identification No. |
|
| November 7, 2022 |
Phibro Animal Health Corporation Declares Quarterly Dividend Exhibit 99.1 For Immediate Release Phibro Animal Health Corporation Declares Quarterly Dividend TEANECK, N.J., November 7, 2022 (Business Wire) ? The Board of Directors of Phibro Animal Health Corporation (Nasdaq:PAHC) today declared a quarterly cash dividend of $0.12 per share on its Class A common stock and Class B common stock, payable on December 21, 2022, to stockholders of record at the clos |
|
| November 7, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): November 7, 2022 Phibro Animal Health Corporation (EXACT NAME OF REGISTRANT AS SPECIFIED IN CHARTER) Delaware 01-36410 13-1840497 (State or other jurisdiction of incorporation) (Commission File Number) (IRS Employer Identification No. |
|
| September 16, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant x Filed by a Party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ? Defin |
|
| September 16, 2022 |
TABLE OF CONTENTS UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549? SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ??) Filed by the Registrant ? ? Filed by a Party other than the Registrant ? ? Check the appropriate box: ? Preliminary Proxy Statement ? ? Confidential, for Use of the Commission Only (as permitted b |
|
| August 24, 2022 |
Phibro Animal Health Corporation Consolidated Results of Operations Exhibit 99.1 ? ? ? ? For Immediate Release ? Phibro Animal Health Corporation Reports Fourth Quarter and Fiscal Year Results, Provides Financial Guidance ? TEANECK, N.J., August 24, 2022 (Business Wire) ? Phibro Animal Health Corporation (Nasdaq:PAHC) (?Phibro? or the ?Company?) today announced financial results for its fourth quarter and fiscal year ended June 30, 2022, and provided financial gui |
|
| August 24, 2022 |
List of Subsidiaries of Phibro Animal Health Corporation. EXHIBIT 21.1 PHIBRO ANIMAL HEALTH CORPORATION LIST OF SUBSIDIARIES ? SUBSIDIARY JURISDICTION 8861 Dice Road LLC ? California ? First Dice Road Company, A California Limited Partnership California Western Magnesium Corp. California Phibro Animal Health Holdings, Inc. Delaware Prince Agri Products, Inc. Delaware Phibro-Tech, Inc. Delaware PhibroWood, LLC ? Delaware ? PMC Quincy, Inc. ? Delaware ? C |
|
| August 24, 2022 |
? ? UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 ? FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): August 24, 2022 Phibro Animal Health Corporation (EXACT NAME OF REGISTRANT AS SPECIFIED IN CHARTER) ? Delaware 001-36410 13-1840497 (State or other jurisdiction of incorporation) (Commission File Number) (IRS Employer Identification No. |
|
| August 24, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K Table of Contents ? ? UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| July 25, 2022 |
Phibro Animal Health Corporation Declares Quarterly Dividend Exhibit 99.1 For Immediate Release Phibro Animal Health Corporation Declares Quarterly Dividend TEANECK, N.J., July 25, 2022 (Business Wire) ? The Board of Directors of Phibro Animal Health Corporation (Nasdaq:PAHC) today declared a quarterly cash dividend of $0.12 per share on its Class A common stock and Class B common stock, payable on September 28, 2022, to stockholders of record at the close |
|
| July 25, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): July 25, 2022 Phibro Animal Health Corporation (EXACT NAME OF REGISTRANT AS SPECIFIED IN CHARTER) Delaware 01-36410 13-1840497 (State or other jurisdiction of incorporation) (Commission File Number) (IRS Employer Identification No. |
|
| May 25, 2022 |
PAHC / Phibro Animal Health Corp / BFI Co., LLC - SC 13D/A Activist Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D/A Under the Securities Exchange Act of 1934 (Amendment No. 17) Phibro Animal Health Corporation (Name of Issuer) Class A Common Stock, par value $0.0001 per share (Title of Class of Securities) 71742Q 106 (CUSIP Number) c/o Jack C. Bendheim Phibro Animal Health Corporation Glenpointe Centre East, 3rd Fl. 300 Frank |
|
| May 4, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): May 4, 2022 Phibro Animal Health Corporation (EXACT NAME OF REGISTRANT AS SPECIFIED IN CHARTER) Delaware 001-36410 13-1840497 (State or other jurisdiction of incorporation) (Commission File Number) (IRS Employer Identification No. |
|
| May 4, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q Table of Contents ? ? UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| May 4, 2022 |
Phibro Animal Health Corporation Consolidated Results of Operations Exhibit 99.1 For Immediate Release Phibro Animal Health Corporation Reports Third Quarter Results, Provides Revised Financial Guidance TEANECK, N.J., May 4, 2022 (Business Wire) ? Phibro Animal Health Corporation (Nasdaq:PAHC) today announced financial results for its third quarter ended March 31, 2022. ? Highlights for the three months ended March 31, 2022 (compared to the three months ended Marc |
|
| May 2, 2022 |
Phibro Animal Health Corporation Declares Quarterly Dividend Exhibit 99.1 For Immediate Release Phibro Animal Health Corporation Declares Quarterly Dividend TEANECK, N.J., May 2, 2022 (Business Wire) ? The Board of Directors of Phibro Animal Health Corporation (Nasdaq:PAHC) today declared a quarterly cash dividend of $0.12 per share on its Class A common stock and Class B common stock, payable on June 22, 2022, to stockholders of record at the close of busi |
|
| May 2, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): May 2, 2022 Phibro Animal Health Corporation (EXACT NAME OF REGISTRANT AS SPECIFIED IN CHARTER) Delaware 01-36410 13-1840497 (State or other jurisdiction of incorporation) (Commission File Number) (IRS Employer Identification No. |
|
| February 10, 2022 |
PAHC / Phibro Animal Health Corp / VANGUARD GROUP INC - SCHEDULE 13G/A Passive Investment SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 8)* Name of issuer: Phibro Animal Health Corp. Class A Title of Class of Securities: Common Stock CUSIP Number: 71742Q106 Date of Event Which Requires Filing of this Statement: December 31, 2021 Check the appropriate box to designate the rule pursuant to which this Sched |
|
| February 9, 2022 |
Phibro Animal Health Corporation Consolidated Results of Operations Exhibit 99.1 For Immediate Release Phibro Animal Health Corporation Reports Second Quarter Results, Provides Revised Financial Guidance TEANECK, N.J., February 9, 2022 (Business Wire) ? Phibro Animal Health Corporation (Nasdaq:PAHC) today announced financial results for its second quarter ended December 31, 2021. ? Highlights for the three months ended December 31, 2021 (compared to the three mont |
|
| February 9, 2022 |
Exhibit 10.25 February 7, 2022 Damian Finio **** Dear Damian: In recognition of your significant contributions to Phibro Animal Health Corporation, a Delaware corporation (the ?Company?), the Company wishes to provide you with severance protections in the event you experience a Qualifying Termination (as defined below), subject to the terms set forth in this letter agreement (this ?Agreement?). Re |
|
| February 9, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): February 9, 2022 Phibro Animal Health Corporation (EXACT NAME OF REGISTRANT AS SPECIFIED IN CHARTER) Delaware 01-36410 13-1840497 (State or other jurisdiction of incorporation) (Commission File Number) (IRS Employer Identification No. |
|
| February 9, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q Table of Contents ? ? UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| February 7, 2022 |
Phibro Animal Health Corporation Declares Quarterly Dividend Exhibit 99.1 Phibro Animal Health Corporation Declares Quarterly Dividend TEANECK, N.J., February 7, 2022 (BUSINESS WIRE) ? The Board of Directors of Phibro Animal Health Corporation (Nasdaq:PAHC) today declared a quarterly cash dividend of $0.12 per share on its Class A common stock and Class B common stock, payable on March 23, 2022, to stockholders of record at the close of business on March 2, |
|
| February 7, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): February 7, 2022 Phibro Animal Health Corporation (EXACT NAME OF REGISTRANT AS SPECIFIED IN CHARTER) Delaware 001-36410 13-1840497 (State or other jurisdiction of incorporation) (Commission File Number) (IRS Employer Identification No. |
|
| January 21, 2022 |
PAHC / Phibro Animal Health Corp / PZENA INVESTMENT MANAGEMENT LLC - SC 13G Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 PHIBRO ANIMAL HEALTH CORP (Name of Issuer) COMMON STOCK (Title of Class of Securities) 71742Q106 (CUSIP Number) December 31, 2021 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is file |
|
| January 12, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): January 12, 2022 Phibro Animal Health Corporation (EXACT NAME OF REGISTRANT AS SPECIFIED IN CHARTER) Delaware 001-36410 13-1840497 (State or other jurisdiction of incorporation) (Commission File Number) (IRS Employer Identification No. |
|
| January 12, 2022 |
Phibro Animal Health Corporation Welcomes FDA Hearing on Mecadox® Exhibit 99.1 Phibro Animal Health Corporation Welcomes FDA Hearing on Mecadox? TEANECK, NJ, January 12, 2022 (Business Wire) - Phibro Animal Health Corporation (NASDAQ:PAHC): Today, the Food and Drug Administration (FDA) provided notice in the Federal Register of its intention to hold a public hearing regarding Mecadox? (carbadox). Mecadox has been approved and sold in the United States for 50 yea |
|
| November 2, 2021 |
Phibro Animal Health Corporation Reports First Quarter Results Exhibit 99.1 For Immediate Release Phibro Animal Health Corporation Reports First Quarter Results TEANECK, N.J., November 2, 2021 (Business Wire) ? Phibro Animal Health Corporation (Nasdaq:PAHC) today announced financial results for its first quarter ended September 30, 2021. ? Highlights for the three months ended September 30, 2021 (compared to the three months ended September 30, 2020) - Net sa |
|
| November 2, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): November 2, 2021 Phibro Animal Health Corporation (EXACT NAME OF REGISTRANT AS SPECIFIED IN CHARTER) Delaware 01-36410 13-1840497 (State or other jurisdiction of incorporation) (Commission File Number) (IRS Employer Identification No. |
|
| November 2, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q Table of Contents ? ? UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| November 2, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): November 2, 2021 (November 1, 2021) Phibro Animal Health Corporation (EXACT NAME OF REGISTRANT AS SPECIFIED IN CHARTER) Delaware 001-36410 13-1840497 (State or other jurisdiction of incorporation) (Commission File Number) (IRS Employer Identification No. |
|
| November 1, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): November 1, 2021 Phibro Animal Health Corporation (EXACT NAME OF REGISTRANT AS SPECIFIED IN CHARTER) Delaware 01-36410 13-1840497 (State or other jurisdiction of incorporation) (Commission File Number) (IRS Employer Identification No. |
|
| November 1, 2021 |
Phibro Animal Health Corporation Declares Quarterly Dividend Exhibit 99.1 Phibro Animal Health Corporation Declares Quarterly Dividend TEANECK, N.J., November 1, 2021 (BUSINESS WIRE) - The Board of Directors of Phibro Animal Health Corporation (Nasdaq:PAHC) today declared a quarterly cash dividend of $0.12 per share on its Class A common stock and Class B common stock, payable on December 15, 2021, to stockholders of record at the close of business on Novem |
|
| September 17, 2021 |
TABLE OF CONTENTS UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ??) Filed by the Registrant ? ? Filed by a Party other than the Registrant ? ? Check the appropriate box: ? Preliminary Proxy Statement ? ? Confidential, for Use of the Commission Only (as permitted by |
|
| September 17, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ??) Filed by the Registrant x Filed by a Party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for Use of the Commission Only (as permitted by Rule 14a-6( |
|
| August 25, 2021 |
Exhibit 99.1 For Immediate Release Phibro Animal Health Corporation Reports Fourth Quarter and Fiscal Year Results, Provides Financial Guidance TEANECK, N.J., August 25, 2021 (Business Wire) ? Phibro Animal Health Corporation (Nasdaq:PAHC) today announced financial results for its fourth quarter and fiscal year ended June 30, 2021, and provided financial guidance for the year ending June 30, 2022. |
|
| August 25, 2021 |
List of Subsidiaries of Phibro Animal Health Corporation. EXHIBIT 21.1 PHIBRO ANIMAL HEALTH CORPORATION LIST OF SUBSIDIARIES ? SUBSIDIARY JURISDICTION First Dice Road Company, A California Limited Partnership California Western Magnesium Corp. California Phibro Animal Health Holdings, Inc. Delaware Prince Agri Products, Inc. Delaware Phibro-Tech, Inc. Delaware C P Chemicals, Inc. New Jersey Phibrochem, Inc. New Jersey OmniGen Research, LLC Oregon Phibro |
|
| August 25, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K Table of Contents ? ? UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| August 25, 2021 |
Exhibit 10.24 ? ? ? CONFIDENTIAL GENERAL RELEASE AND SEPARATION AGREEMENT ? This General Release and Separation Agreement and (?Agreement?) is between Richard G. Johnson (?you?) and Phibro Animal Health Corporation (?PAHC? or ?the Company?). It is intended to fully and finally resolve and compromise all potential issues and claims surrounding your employment with, and the termination of, your empl |
|
| August 25, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): August 25, 2021 (August 25, 2021) Phibro Animal Health Corporation (EXACT NAME OF REGISTRANT AS SPECIFIED IN CHARTER) Delaware 001-36410 13-1840497 (State or other jurisdiction of incorporation) (Commission File Number) (IRS Employer Identification No. |
|
| July 26, 2021 |
Phibro Animal Health Corporation Declares Quarterly Dividend Exhibit 99.1 Phibro Animal Health Corporation Declares Quarterly Dividend TEANECK, N.J., July 26, 2021 (BUSINESS WIRE) ? The Board of Directors of Phibro Animal Health Corporation (Nasdaq:PAHC) today declared a quarterly cash dividend of $0.12 per share on its Class A common stock and Class B common stock, payable on September 22, 2021, to stockholders of record at the close of business on Septemb |
|
| July 26, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): July 26, 2021 Phibro Animal Health Corporation (EXACT NAME OF REGISTRANT AS SPECIFIED IN CHARTER) Delaware 01-36410 13-1840497 (State or other jurisdiction of incorporation) (Commission File Number) (IRS Employer Identification No. |
|
| June 25, 2021 |
PAHC / Phibro Animal Health Corp / BFI Co., LLC - SCHEDULE 13D/A Activist Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D/A Under the Securities Exchange Act of 1934 (Amendment No. 16) Phibro Animal Health Corporation (Name of Issuer) Class A Common Stock, par value $0.0001 per share (Title of Class of Securities) 71742Q 106 (CUSIP Number) c/o Jack C. Bendheim Phibro Animal Health Corporation Glenpointe Centre East, 3rd Fl. 300 Frank |
|
| May 6, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): May 6, 2021 Phibro Animal Health Corporation (EXACT NAME OF REGISTRANT AS SPECIFIED IN CHARTER) Delaware 001-36410 13-1840497 (State or other jurisdiction of incorporation) (Commission File Number) (IRS Employer Identification No. |
|
| May 6, 2021 |
Table of Contents ? ? UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| May 6, 2021 |
Phibro Animal Health Corporation Reports Third Quarter and Year-to-Date Results Exhibit 99.1 For Immediate Release Phibro Animal Health Corporation Reports Third Quarter and Year-to-Date Results TEANECK, N.J., May 6, 2021 (Business Wire) ? Phibro Animal Health Corporation (NASDAQ: PAHC) today announced financial results for its third quarter and year-to-date period ended March 31, 2021. Highlights for the March 31, 2021 quarter (compared to the quarter ended March 31, 2020) - |
|
| May 3, 2021 |
Phibro Animal Health Corporation Declares Quarterly Dividend Exhibit 99.1 Phibro Animal Health Corporation Declares Quarterly Dividend TEANECK, N.J., May 3, 2021 (BUSINESS WIRE) ? The Board of Directors of Phibro Animal Health Corporation (Nasdaq:PAHC) today declared a quarterly cash dividend of $0.12 per share on its Class A common stock and Class B common stock, payable on June 23, 2021, to stockholders of record at the close of business on June 2, 2021. |
|
| May 3, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): May 3, 2021 Phibro Animal Health Corporation (EXACT NAME OF REGISTRANT AS SPECIFIED IN CHARTER) Delaware 001-36410 13-1840497 (State or other jurisdiction of incorporation) (Commission File Number) (IRS Employer Identification No. |
|
| April 22, 2021 |
Exhibit 10.1 Execution Version Published Deal CUSIP: 71742TAD2 Revolver CUSIP: 71742TAE0 Term Loan CUSIP: 71742TAF7 AMENDED AND RESTATED CREDIT AGREEMENT Dated as of April 22, 2021 among PHIBRO ANIMAL HEALTH CORPORATION, as the Borrower, BANK OF AMERICA, N.A., as Administrative Agent, Collateral Agent and L/C Issuer, and THE LENDERS PARTY HERETO Arranged By: BOFA SECURITIES, INC., and CO?PERATIEVE |
|
| April 22, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): April 22, 2021 Phibro Animal Health Corporation (EXACT NAME OF REGISTRANT AS SPECIFIED IN CHARTER) Delaware 01-36410 13-1840497 (State or other jurisdiction of incorporation) (Commission File Number) (IRS Employer Identification No. |
|
| April 22, 2021 |
Phibro Animal Health Corporation Announces $550 million Debt Refinancing Exhibit 99.1 Phibro Animal Health Corporation Announces $550 million Debt Refinancing TEANECK, N.J., April 22, 2021, (Business Wire) - Phibro Animal Health Corporation (NASDAQ:PAHC) announced today that on April 22, 2021, the Company entered into an amended and restated credit agreement. Under the amended and restated credit agreement, the lenders agreed to extend credit to the Company in the form |
|
| February 10, 2021 |
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 7)* Name of issuer: Phibro Animal Health Corp. Class A Title of Class of Securities: Common Stock CUSIP Number: 71742Q106 Date of Event Which Requires Filing of this Statement: December 31, 2020 Check the appropriate box to designate the rule pursuant to which this Sched |
|
| February 3, 2021 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended December 31, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number |
|
| February 3, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): February 3, 2021 Phibro Animal Health Corporation (EXACT NAME OF REGISTRANT AS SPECIFIED IN CHARTER) Delaware 01-36410 13-1840497 (State or other jurisdiction of incorporation) (Commission File Number) (IRS Employer Identification No. |
|
| February 3, 2021 |
Phibro Animal Health Corporation Reports Second Quarter Results Exhibit 99.1 For Immediate Release Phibro Animal Health Corporation Reports Second Quarter Results TEANECK, N.J., February 3, 2021 (Business Wire) – Phibro Animal Health Corporation (NASDAQ:PAHC) today announced financial results for its second quarter ended December 31, 2020. Highlights for the December 31, 2020 quarter (compared to the quarter ended December 31, 2019) - Net sales of $206 million |
|
| February 1, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): February 1,2021 Phibro Animal Health Corporation (EXACT NAME OF REGISTRANT AS SPECIFIED IN CHARTER) Delaware 01-36410 13-1840497 (State or other jurisdiction of incorporation) (Commission File Number) (IRS Employer Identification No. |
|
| February 1, 2021 |
Phibro Animal Health Corporation Declares Quarterly Dividend Exhibit 99.1 Phibro Animal Health Corporation Declares Quarterly Dividend TEANECK, N.J., February 1, 2021 (BUSINESS WIRE) – The Board of Directors of Phibro Animal Health Corporation (Nasdaq:PAHC) today declared a quarterly cash dividend of $0.12 per share on its Class A common stock and Class B common stock, payable on March 24, 2021, to stockholders of record at the close of business on March 3, |
|
| December 15, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D/A Under the Securities Exchange Act of 1934 (Amendment No. 15) Phibro Animal Health Corporation (Name of Issuer) Class A Common Stock, par value $0.0001 per share (Title of Class of Securities) 71742Q 106 (CUSIP Number) c/o Jack C. Bendheim Phibro Animal Health Corporation Glenpointe Centre East, 3rd Fl. 300 Frank |
|
| November 4, 2020 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Numbe |
|
| November 4, 2020 |
Exhibit 10.2 November 2, 2020 Richard G. Johnson *** *** Dear Dick: This letter is to confirm our recent discussions regarding your voluntary retirement from your current position as Chief Financial Officer of Phibro Animal Health Corporation (the “Company”) effective November 15, 2020. As discussed, you have agreed to take on a new position with the Company, as Finance Advisor, for a period begin |
|
| November 4, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): November 4, 2020 Phibro Animal Health Corporation (EXACT NAME OF REGISTRANT AS SPECIFIED IN CHARTER) Delaware 001-36410 13-1840497 (State or other jurisdiction of incorporation) (Commission File Number) (IRS Employer Identification No. |
|
| November 4, 2020 |
Phibro Animal Health Corporation Reports First Quarter Results Exhibit 99.1 For Immediate Release Phibro Animal Health Corporation Reports First Quarter Results TEANECK, N.J., November 4, 2020 (Business Wire) – Phibro Animal Health Corporation (NASDAQ:PAHC) today announced its financial results for its first quarter ended September 30, 2020. Highlights for the September 30, 2020 quarter (compared to the September 2019 quarter) - Net sales of $195 million, an |
|
| November 4, 2020 |
Exhibit 10.1 September 14, 2020 Damian L. Finio *** Dear Damian, I am pleased to present an offer of employment to you with Phibro Animal Health Corporation as Chief Financial Officer, Phibro Animal Health Corporation, reporting to me. Our offer to you is as follows: Start Date Your anticipated start date with the Company will be October 26, 2020. This date presumes that you have satisfactorily cl |
|
| November 3, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): November 3, 2020 (November 2, 2020) Phibro Animal Health Corporation (EXACT NAME OF REGISTRANT AS SPECIFIED IN CHARTER) Delaware 01-36410 13-1840497 (State or other jurisdiction of incorporation) (Commission File Number) (IRS Employer Identification No. |
|
| November 2, 2020 |
Phibro Animal Health Corporation Declares Quarterly Dividend Exhibit 99.1 Phibro Animal Health Corporation Declares Quarterly Dividend TEANECK, N.J., November 2, 2020 (BUSINESS WIRE) – The Board of Directors of Phibro Animal Health Corporation (Nasdaq:PAHC) today declared a quarterly cash dividend of $0.12 per share on its Class A common stock and Class B common stock, payable on December 16, 2020, to stockholders of record at the close of business on Novem |
|
| November 2, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): November 2, 2020 Phibro Animal Health Corporation (EXACT NAME OF REGISTRANT AS SPECIFIED IN CHARTER) Delaware 01-36410 13-1840497 (State or other jurisdiction of incorporation) (Commission File Number) (IRS Employer Identification No. |
|
| September 18, 2020 |
TABLE OF CONTENTS UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule |
|
| September 18, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant x Filed by a Party other than the Registrant ¨ Check the appropriate box: ¨ Preliminary Proxy Statement ¨ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6( |
|
| September 17, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): September 17, 2020 (September 11, 2020) Phibro Animal Health Corporation (EXACT NAME OF REGISTRANT AS SPECIFIED IN CHARTER) Delaware 01-36410 13-1840497 (State or other jurisdiction of incorporation) (Commission File Number) (IRS Employer Identification No. |
|
| September 17, 2020 |
Phibro Animal Health Corporation Announces Chief Financial Officer Changes Exhibit 99.1 For Immediate Release Phibro Animal Health Corporation Announces Chief Financial Officer Changes TEANECK, N.J., September 17, 2020 (Business Wire) - Phibro Animal Health Corporation (the “Company” or “Phibro”) today announced that Richard Johnson, Phibro’s Chief Financial Officer, has informed the Company that he will retire from his position effective November 15, 2020, subsequent to |
|
| August 26, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): August 26, 2020 (August 26, 2020) Phibro Animal Health Corporation (EXACT NAME OF REGISTRANT AS SPECIFIED IN CHARTER) Delaware 01-36410 13-1840497 (State or other jurisdiction of incorporation) (Commission File Number) (IRS Employer Identification No. |
|
| August 26, 2020 |
Exhibit 10.18 May 6, 2019 Rob Aukerman *** *** Dear Rob, I am pleased to present an offer of employment to you with Phibro Animal Health Corporation as President, North America Region, reporting to me. Our offer to you is as follows: Start Date Your anticipated start date will be May 20, 2019. This date presumes that you have satisfactorily cleared the pre-employment background check and substance |
|
| August 26, 2020 |
Exhibit 99.1 For Immediate Release Phibro Animal Health Corporation Reports Fourth Quarter and Fiscal Year Results, Provides Guidance for Its Fiscal First Quarter TEANECK, N.J., August 26, 2020 (Business Wire) – Phibro Animal Health Corporation (NASDAQ:PAHC) today announced its financial results for its fourth quarter and fiscal year ended June 30, 2020. Highlights for the June 2020 quarter (compa |
|
| August 26, 2020 |
PHIBRO ANIMAL HEALTH CORPORATION LIST OF SUBSIDIARIES EXHIBIT 21.1 PHIBRO ANIMAL HEALTH CORPORATION LIST OF SUBSIDIARIES SUBSIDIARY JURISDICTION First Dice Road Company, a California Ltd. Partnership California Western Magnesium Corp. California Phibro Animal Health Holdings, Inc. Delaware Prince Agri Products, Inc. Delaware Phibro-Tech, Inc. Delaware C P Chemicals, Inc. New Jersey Phibrochem, Inc. New Jersey OmniGen Research, LLC Oregon Phibro Anima |
|
| August 26, 2020 |
TABLE OF CONTENTS UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended June 30, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission F |
|
| July 27, 2020 |
Phibro Animal Health Corporation Declares Quarterly Dividend Exhibit 99.1 Phibro Animal Health Corporation Declares Quarterly Dividend TEANECK, N.J., July 27, 2020 (BUSINESS WIRE) – The Board of Directors of Phibro Animal Health Corporation (Nasdaq:PAHC) today declared a quarterly cash dividend of $0.12 per share on its Class A common stock and Class B common stock, payable on September 23, 2020, to stockholders of record at the close of business on Septemb |
|
| July 27, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): July 27, 2020 Phibro Animal Health Corporation (EXACT NAME OF REGISTRANT AS SPECIFIED IN CHARTER) Delaware 01-36410 13-1840497 (State or other jurisdiction of incorporation) (Commission File Number) (IRS Employer Identification No. |
|
| July 17, 2020 |
Phibro Animal Health Corporation Reiterates Safety of Mecadox® Exhibit 99.1 Phibro Animal Health Corporation Reiterates Safety of Mecadox® TEANECK, NJ, July 17, 2020 (Business Wire) - (NASDAQ:PAHC) Today, the Food and Drug Administration (FDA) provided notice of Federal Register publication of its intention to take a number of actions related to its ongoing review of the regulatory status of Mecadox® (carbadox). Mecadox has been approved and sold in the Unite |
|
| July 17, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): July 17, 2020 Phibro Animal Health Corporation (EXACT NAME OF REGISTRANT AS SPECIFIED IN CHARTER) Delaware 01-36410 13-1840497 (State or other jurisdiction of incorporation) (Commission File Number) (IRS Employer Identification No. |
|
| June 8, 2020 |
PAHC / Phibro Animal Health Corporation / BFI Co., LLC - SC 13D/A Activist Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D/A Under the Securities Exchange Act of 1934 (Amendment No. 14) Phibro Animal Health Corporation (Name of Issuer) Class A Common Stock, par value $0.0001 per share (Title of Class of Securities) 71742Q 106 (CUSIP Number) c/o Jack C. Bendheim Phibro Animal Health Corporation Glenpointe Centre East, 3rd Fl. 300 Frank |
|
| May 7, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): May 7, 2020 (May 7, 2020) Phibro Animal Health Corporation (EXACT NAME OF REGISTRANT AS SPECIFIED IN CHARTER) Delaware 01-36410 13-1840497 (State or other jurisdiction of incorporation) (Commission File Number) (IRS Employer Identification No. |
|
| May 7, 2020 |
Phibro Animal Health Corporation Reports Third Quarter Results Exhibit 99.1 For Immediate Release Phibro Animal Health Corporation Reports Third Quarter Results TEANECK, N.J., May 7, 2020 (Business Wire) – Phibro Animal Health Corporation (NASDAQ:PAHC) today announced its financial results for its third quarter ended March 31, 2020. Highlights for the March 2020 quarter (compared to the March 2019 quarter) - Net sales of $211 million, an increase of $5 millio |
|
| May 7, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-36410 Phibro An |
|
| May 4, 2020 |
Phibro Animal Health Corporation Declares Quarterly Dividend Exhibit 99.1 Phibro Animal Health Corporation Declares Quarterly Dividend TEANECK, N.J., May 4, 2020 (BUSINESS WIRE) – The Board of Directors of Phibro Animal Health Corporation (Nasdaq:PAHC) today declared a quarterly cash dividend of $0.12 per share on its Class A common stock and Class B common stock, payable on June 24, 2020, to stockholders of record at the close of business on June 3, 2020. |
|
| May 4, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): May 4, 2020 (May 4, 2020) Phibro Animal Health Corporation (EXACT NAME OF REGISTRANT AS SPECIFIED IN CHARTER) Delaware 01-36410 13-1840497 (State or other jurisdiction of incorporation) (Commission File Number) (IRS Employer Identification No. |
|
| February 12, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): February 12, 2020 (February 7, 2020) Phibro Animal Health Corporation (EXACT NAME OF REGISTRANT AS SPECIFIED IN CHARTER) Delaware 01-36410 13-1840497 (State or other jurisdiction of incorporation) (Commission File Number) (IRS Employer Identification No. |
|
| February 12, 2020 |
PAHC / Phibro Animal Health Corporation / VANGUARD GROUP INC - SCHEDULE 13G/A Passive Investment SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 6)* Name of issuer: Phibro Animal Health Corp Title of Class of Securities: Common Stock CUSIP Number: 71742Q106 Date of Event Which Requires Filing of this Statement: December 31, 2019 Check the appropriate box to designate the rule pursuant to which this Schedule is fi |
|
| February 3, 2020 |
PAHC / Phibro Animal Health Corporation 10-Q - Quarterly Report - FORM 10-Q TABLE OF CONTENTS UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended December 31, 2019 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number |
|
| February 3, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): February 3, 2020 (February 3, 2020) Phibro Animal Health Corporation (EXACT NAME OF REGISTRANT AS SPECIFIED IN CHARTER) Delaware 01-36410 13-1840497 (State or other jurisdiction of incorporation) (Commission File Number) (IRS Employer Identification No. |
|
| February 3, 2020 |
Phibro Animal Health Corporation Declares Quarterly Dividend Exhibit 99.2 Phibro Animal Health Corporation Declares Quarterly Dividend TEANECK, N.J., February 3, 2020 (Business Wire) – The Board of Directors of Phibro Animal Health Corporation (Nasdaq:PAHC) today declared a quarterly cash dividend of $0.12 per share on its Class A common stock and Class B common stock, payable on March 25, 2020, to stockholders of record at the close of business on March 4, |
|
| February 3, 2020 |
Phibro Animal Health Corporation Reports Second Quarter Results Exhibit 99.1 For Immediate Release Phibro Animal Health Corporation Reports Second Quarter Results TEANECK, N.J., February 3, 2020 (Business Wire) – Phibro Animal Health Corporation (NASDAQ:PAHC) today announced its financial results for its second quarter ended December 31, 2019. Highlights for the December 2019 quarter (compared to the December 2018 quarter) - Net sales of $214 million, a decrea |
|
| December 20, 2019 |
PAHC / Phibro Animal Health Corporation / BFI Co., LLC - SC 13D/A Activist Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D/A Under the Securities Exchange Act of 1934 (Amendment No. 13) Phibro Animal Health Corporation (Name of Issuer) Class A Common Stock, par value $0.0001 per share (Title of Class of Securities) 71742Q 106 (CUSIP Number) c/o Jack C. Bendheim Phibro Animal Health Corporation Glenpointe Centre East, 3rd Fl. 300 Frank |
|
| November 5, 2019 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): November 5, 2019 (November 4, 2019) Phibro Animal Health Corporation (EXACT NAME OF REGISTRANT AS SPECIFIED IN CHARTER) Delaware 01-36410 13-1840497 (State or other jurisdiction of incorporation) (Commission File Number) (IRS Employer Identification No. |
|
| November 4, 2019 |
Phibro Animal Health Corporation Reports First Quarter Results Exhibit 99.1 November 1, 2019 For Immediate Release Phibro Animal Health Corporation Reports First Quarter Results TEANECK, N.J., November 4, 2019 (Business Wire) – Phibro Animal Health Corporation (NASDAQ:PAHC) today announced its financial results for its first quarter ended September 30, 2019. Highlights for the September 2019 quarter (compared to the September 2018 quarter) - Net sales of $190 |
|
| November 4, 2019 |
Phibro Animal Health Corporation Declares Quarterly Dividend Exhibit 99.2 Phibro Animal Health Corporation Declares Quarterly Dividend TEANECK, N.J., November 4, 2019 (GLOBE NEWSWIRE) – The Board of Directors of Phibro Animal Health Corporation (Nasdaq:PAHC) today declared a quarterly cash dividend of $0.12 per share on its Class A common stock and Class B common stock, payable on December 18, 2019, to stockholders of record at the close of business on Nove |
|
| November 4, 2019 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): November 4, 2019 (November 4, 2019) Phibro Animal Health Corporation (EXACT NAME OF REGISTRANT AS SPECIFIED IN CHARTER) Delaware 01-36410 13-1840497 (State or other jurisdiction of incorporation) (Commission File Number) (IRS Employer Identification No. |
|
| November 4, 2019 |
PAHC / Phibro Animal Health Corporation 10-Q - Quarterly Report - FORM 10-Q TABLE OF CONTENTS UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2019 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Numbe |
|
| November 4, 2019 |
Exhibit 2.1 Execution Copy ASSET PURCHASE AGREEMENT By and Among PHIBRO ANIMAL HEALTH CORPORATION, as Purchaser OSPREY BIOTECHNICS, INC. as Company and together with LAUREN DANIELSON and VINCENT SCUILLA as Selling Parties August 1, 2019 ARTICLE 1 DEFINITIONS 4 ARTICLE 2 PURCHASE AND SALE OF ASSETS 13 Section 2.1 Sale and Transfer of Assets 13 Section 2.2 Purchase Price 15 Section 2.3 Closing Consi |
|
| September 20, 2019 |
PAHC / Phibro Animal Health Corporation DEFA14A - - DEFA14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant x Filed by a Party other than the Registrant ¨ Check the appropriate box: ¨ Preliminary Proxy Statement ¨ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6( |
|
| September 20, 2019 |
PAHC / Phibro Animal Health Corporation DEF 14A - - DEF 14A TABLE OF CONTENTS UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule |
|
| August 27, 2019 |
Exhibit 99.1 For Immediate Release Phibro Animal Health Corporation Reports Fourth Quarter and Fiscal Year Results, Presents Financial Guidance TEANECK, N.J., August 27, 2019 (Business Newswire) – Phibro Animal Health Corporation (NASDAQ:PAHC) today announced its financial results for its fourth quarter and fiscal year ended June 30, 2019 and presented financial guidance for the new fiscal year. H |
|
| August 27, 2019 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): August 27, 2019 Phibro Animal Health Corporation (Exact name of registrant as specified in its charter) Delaware 01-36410 13-1840497 (State or other jurisdiction of incorporation) (Commission File Number) (IRS Employer Identification No. |
|
| August 27, 2019 |
Exhibit 10.21 Phibro ANIMAL HEALTH November 16, 2009 Dear Tom: This letter amends your employment agreement as set forth in your signed offer letter dated November 1, 2006 (and signed by you on November 3, 2008) (“Offer Letter Agreement”). Except as stated below, the terms of the Offer Letter Agreement shall remain in effect. Base Salary and Compensation The “Base Salary and Compensation” provisio |
|
| August 27, 2019 |
PAHC / Phibro Animal Health Corporation 10-K - Annual Report - 10-K TABLE OF CONTENTS UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended June 30, 2019 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-36410 |
|
| August 27, 2019 |
EXHIBIT 4.2 DESCRIPTION OF THE REGISTRANT’S SECURITIES REGISTERED PURSUANT TO SECTION 12 OF THE SECURITIES EXCHANGE ACT OF 1934 Description of Class A common stock The following summary of Phibro Animal Health Corporation’s Class A common stock does not purport to be complete and is subject to our amended and restated certificate of incorporation, our amended and restated bylaws and the provisions |
|
| August 27, 2019 |
Exhibit 10.20 Phibro ANIMAL HEALTH CORPORATION November 3, 2006 Dear Thomas: On behalf of Gerald K. Carlson, Chief Executive Officer, I am pleased to present an offer of employment to you with Phibro Animal Health Corporation as Senior Vice President, General Counsel and Corporate Secretary reporting to Mr. Carlson. The offer to you is as follows: Start Date November 15, 2006 Base Salary and Compe |
|
| August 27, 2019 |
Exhibit 10.22 December 16, 2011 Dear Tom: This letter amends your employment agreement as set forth in your offer letter dated November 1, 2006, as amended by the letter agreement dated November 16, 2009 (“Offer Letter Agreement”). Except as stated below, the terms of the Offer Letter Agreement shall remain in effective. The following is added as the last sentence to the section titled “Section 40 |
|
| August 27, 2019 |
List of Subsidiaries of Phibro Animal Health Corporation. EXHIBIT 21.1 PHIBRO ANIMAL HEALTH CORPORATION LIST OF SUBSIDIARIES SUBSIDIARY JURISDICTION Prince Agri Products, Inc. Delaware OmniGen Research, LLC Oregon Phibro Animal Health Holdings, Inc. Delaware Phibro Animal Health de Argentina SRL Argentina Biotay S.A. Argentina Phibro Animal PTY Limited Australia Phibro Animal Health (Belgium) S.A. Belgium Phibro Saude Animal Internacional Ltda. Brazil Ph |
|
| August 1, 2019 |
Phibro Animal Health Corporation Acquires Business of Osprey Biotechnics, Inc. Exhibit 99.1 Phibro Animal Health Corporation Acquires Business of Osprey Biotechnics, Inc. TEANECK, N.J., August 1, 2019 (Business Wire) – Phibro Animal Health Corporation (“Phibro”) (NASDAQ:PAHC) today announced it has acquired the business and assets of Osprey Biotechnics, Inc. (“Osprey”), a privately held developer and marketer of innovative microbial products. Acquiring the Osprey business st |
|
| August 1, 2019 |
Regulation FD Disclosure, Entry into a Material Definitive Agreement UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): August 1, 2019 Phibro Animal Health Corporation (Exact name of registrant as specified in its charter) Delaware 01-36410 13-1840497 (State or other jurisdiction of incorporation) (Commission File Number) (IRS Employer Identification No. |
|
| July 29, 2019 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): July 29, 2019 (July 29, 2019) Phibro Animal Health Corporation (EXACT NAME OF REGISTRANT AS SPECIFIED IN CHARTER) Delaware 01-36410 13-1840497 (State or other jurisdiction of incorporation) (Commission File Number) (IRS Employer Identification No. |
|
| July 29, 2019 |
Phibro Animal Health Corporation Declares Quarterly Dividend Exhibit 99.1 Phibro Animal Health Corporation Declares Quarterly Dividend TEANECK, N.J., July 29, 2019 (GLOBE NEWSWIRE) – The Board of Directors of Phibro Animal Health Corporation (Nasdaq:PAHC) today declared a quarterly cash dividend of $0.12 per share on its Class A common stock and Class B common stock, payable on September 25, 2019, to stockholders of record at the close of business on Septem |
|
| June 26, 2019 |
PAHC / Phibro Animal Health Corporation / BFI Co., LLC - SC 13D/A Activist Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D/A Under the Securities Exchange Act of 1934 (Amendment No. 12) Phibro Animal Health Corporation (Name of Issuer) Class A Common Stock, par value $0.0001 per share (Title of Class of Securities) 71742Q 106 (CUSIP Number) c/o Jack C. Bendheim Phibro Animal Health Corporation Glenpointe Centre East, 3rd Fl. 300 Frank |
|
| May 10, 2019 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): May 10, 2019 (May 8, 2019) Phibro Animal Health Corporation (EXACT NAME OF REGISTRANT AS SPECIFIED IN CHARTER) Delaware 01-36410 13-1840497 (State or other jurisdiction of incorporation) (Commission File Number) (IRS Employer Identification No. |
|
| May 6, 2019 |
Phibro Animal Health Corporation Reports Third Quarter Results Exhibit 99.1 For Immediate Release Phibro Animal Health Corporation Reports Third Quarter Results TEANECK, N.J., May 6, 2019 (GLOBE NEWSWIRE) – Phibro Animal Health Corporation (NASDAQ:PAHC) today announced its financial results for its third quarter ended March 31, 2019. Highlights for the March 2019 quarter (compared to the March 2018 quarter) - Net sales of $206 million, a decrease of $3 millio |
|
| May 6, 2019 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): May 6, 2019 (May 6, 2019) Phibro Animal Health Corporation (EXACT NAME OF REGISTRANT AS SPECIFIED IN CHARTER) Delaware 01-36410 13-1840497 (State or other jurisdiction of incorporation) (Commission File Number) (IRS Employer Identification No. |
|
| May 6, 2019 |
Phibro Animal Health Corporation Declares Quarterly Dividend Exhibit 99.2 Phibro Animal Health Corporation Declares Quarterly Dividend TEANECK, N.J., May 6, 2019 (GLOBE NEWSWIRE) – The Board of Directors of Phibro Animal Health Corporation (Nasdaq:PAHC) today declared a quarterly cash dividend of $0.12 per share on its Class A common stock and Class B common stock, payable on June 26, 2019, to stockholders of record at the close of business on June 5, 2019. |
|
| May 6, 2019 |
PAHC / Phibro Animal Health Corporation 10-Q Quarterly Report FORM 10-Q TABLE OF CONTENTS UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2019 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001- |
|
| February 11, 2019 |
PAHC / Phibro Animal Health Corporation / VANGUARD GROUP INC Passive Investment phibroanimalhealthcorp.htm - Generated by SEC Publisher for SEC Filing SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 5 )* Name of issuer: Phibro Animal Health Corp Title of Class of Securities: Common Stock CUSIP Number: 71742Q106 Date of Event Which Requires Filing of this Statement: December 31, 2018 Check the app |
|
| February 6, 2019 |
Phibro Animal Health Corporation Consolidated Results of Operations Exhibit 99.1 For Immediate Release Phibro Animal Health Corporation Reports Second Quarter Results TEANECK, N.J., February 6, 2019 (GLOBE NEWSWIRE) – Phibro Animal Health Corporation (NASDAQ:PAHC) today announced its financial results for its second quarter ended December 31, 2018. Highlights for the December 2018 quarter (compared to the December 2017 quarter) – Net sales of $218 million, an incr |
|
| February 6, 2019 |
Phibro Animal Health Corporation Declares Quarterly Dividend Exhibit 99.2 Phibro Animal Health Corporation Declares Quarterly Dividend TEANECK, N.J., February 6, 2019 (GLOBE NEWSWIRE) – The Board of Directors of Phibro Animal Health Corporation (Nasdaq:PAHC) today declared a quarterly cash dividend of $0.12 per share on its Class A common stock and Class B common stock, payable on March 27, 2019, to stockholders of record at the close of business on March 6 |
|
| February 6, 2019 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): February 6, 2019 (February 6, 2019) Phibro Animal Health Corporation (EXACT NAME OF REGISTRANT AS SPECIFIED IN CHARTER) Delaware 01-36410 13-1840497 (State or other jurisdiction of incorporation) (Commission File Number) (IRS Employer Identification No. |
|
| February 6, 2019 |
PAHC / Phibro Animal Health Corporation FORM 10-Q (Quarterly Report) TABLE OF CONTENTS UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended December 31, 2018 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 0 |
|
| November 6, 2018 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): November 6, 2018 (November 5, 2018) Phibro Animal Health Corporation (EXACT NAME OF REGISTRANT AS SPECIFIED IN CHARTER) Delaware 01-36410 13-1840497 (State or other jurisdiction of incorporation) (Commission File Number) (IRS Employer Identification No. |
|
| November 6, 2018 |
Phibro Animal Health Corporation Reports First Quarter Results, Updates Financial Guidance Exhibit 99.1 For Immediate Release Phibro Animal Health Corporation Reports First Quarter Results, Updates Financial Guidance TEANECK, N.J., November 6, 2018 (GLOBE NEWSWIRE) – Phibro Animal Health Corporation (NASDAQ:PAHC) today announced its financial results for its first quarter ended September 30, 2018, and presented updated financial guidance for the fiscal year. Highlights for the September |
|
| November 6, 2018 |
Exhibit 10.18 CONFIDENTIAL TREATMENT REQUESTED UNDER 17 C.F.R. SECTIONS 200.80(b)(4), 200.83 AND 230.24b-2. [*****] INDICATES OMITTED MATERIAL THAT IS THE SUBJECT OF A CONFIDENTIAL TREATMENT REQUEST FILED SEPARATELY WITH THE COMMISSION. THE OMITTED MATERIAL HAS BEEN FILED SEPARATELY WITH THE COMMISSION. CONFIDENTIAL Execution Version FIRST AMENDMENT TO INTELLECTUAL PROPERTY PURCHASE AGREEMENT This |
|
| November 6, 2018 |
PAHC / Phibro Animal Health Corporation FORM 10-Q (Quarterly Report) TABLE OF CONTENTS UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2018 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: |
|
| November 5, 2018 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): November 5, 2018 (November 5, 2018) Phibro Animal Health Corporation (EXACT NAME OF REGISTRANT AS SPECIFIED IN CHARTER) Delaware 01-36410 13-1840497 (State or other jurisdiction of incorporation) (Commission File Number) (IRS Employer Identification No. |
|
| November 5, 2018 |
Phibro Animal Health Corporation Declares Quarterly Dividend Exhibit 99.1 Phibro Animal Health Corporation Declares Quarterly Dividend TEANECK, N.J., November 5, 2018 (GLOBE NEWSWIRE) – The Board of Directors of Phibro Animal Health Corporation (Nasdaq:PAHC) today declared a quarterly cash dividend of $0.12 per share on its Class A common stock and Class B common stock, payable on December 19, 2018, to stockholders of record at the close of business on Nove |
|
| September 21, 2018 |
PAHC / Phibro Animal Health Corporation DEFINITIVE ADDITIONAL MATERIALS UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant x Filed by a Party other than the Registrant ¨ Check the appropriate box: ¨ Preliminary Proxy Statement ¨ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6( |
|
| September 21, 2018 |
PAHC / Phibro Animal Health Corporation DEFINITIVE PROXY STATEMENT TABLE OF CONTENTS UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permit |
|
| September 17, 2018 |
PAHC / Phibro Animal Health Corporation / BFI Co., LLC - SC 13D/A Activist Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D/A Under the Securities Exchange Act of 1934 (Amendment No. 11) Phibro Animal Health Corporation (Name of Issuer) Class A Common Stock, par value $0.0001 per share (Title of Class of Securities) 71742Q 106 (CUSIP Number) c/o Jack C. Bendheim Phibro Animal Health Corporation Glenpointe Centre East, 3rd Fl. 300 Frank |
|
| August 27, 2018 |
Exhibit 99.1 For Immediate Release Phibro Animal Health Corporation Reports Fourth Quarter and Fiscal Year Results, Presents Financial Guidance and Announces an Increased Dividend TEANECK, N.J., August 27, 2018 (GLOBE NEWSWIRE) – Phibro Animal Health Corporation (NASDAQ:PAHC) today announced its financial results for its fourth quarter and fiscal year ended June 30, 2018, presented financial guida |
|
| August 27, 2018 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): August 27, 2018 (August 27, 2018) Phibro Animal Health Corporation (EXACT NAME OF REGISTRANT AS SPECIFIED IN CHARTER) Delaware 01-36410 13-1840497 (State or other jurisdiction of incorporation) (Commission File Number) (IRS Employer Identification No. |
|
| August 27, 2018 |
List of Subsidiaries of Phibro Animal Health Corporation. EXHIBIT 21.1 PHIBRO ANIMAL HEALTH CORPORATION LIST OF SUBSIDIARIES SUBSIDIARY JURISDICTION Prince Agri Products, Inc. Delaware OmniGen Research, LLC Oregon Phibro Animal Health Holdings, Inc. Delaware Phibro Animal Health de Argentina SRL Argentina Biotay S.A. Argentina Phibro Animal PTY Limited Australia Phibro Animal Health (Belgium) S.A. Belgium Phibro Saude Animal Internacional Ltda. Brazil Ph |
|
| August 27, 2018 |
PAHC / Phibro Animal Health Corporation FORM 10-K (Annual Report) TABLE OF CONTENTS UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended June 30, 2018 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-36410 |
|
| July 31, 2018 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): July 31, 2018 (July 31, 2018) Phibro Animal Health Corporation (Exact name of registrant as specified in its charter) Delaware 01-36410 13-1840497 (State or other jurisdiction of incorporation) (Commission File Number) (IRS Employer Identification No. |
|
| July 30, 2018 |
Phibro Animal Health Corporation Declares Quarterly Dividend Exhibit 99.1 Phibro Animal Health Corporation Declares Quarterly Dividend TEANECK, N.J., July 30, 2018 (GLOBE NEWSWIRE) – The Board of Directors of Phibro Animal Health Corporation (Nasdaq:PAHC) today declared a quarterly cash dividend of $0.10 per share on its Class A common stock and Class B common stock, payable on September 26, 2018, to stockholders of record at the close of business on Septem |
|
| July 30, 2018 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): July 30, 2018 (July 30, 2018) Phibro Animal Health Corporation (EXACT NAME OF REGISTRANT AS SPECIFIED IN CHARTER) Delaware 01-36410 13-1840497 (State or other jurisdiction of incorporation) (Commission File Number) (IRS Employer Identification No. |
|
| June 26, 2018 |
PAHC / Phibro Animal Health Corporation / BFI Co., LLC - SC 13D/A Activist Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D/A Under the Securities Exchange Act of 1934 (Amendment No. 10) Phibro Animal Health Corporation (Name of Issuer) Class A Common Stock, par value $0.0001 per share (Title of Class of Securities) 71742Q 106 (CUSIP Number) c/o Jack C. Bendheim Phibro Animal Health Corporation Glenpointe Centre East, 3rd Fl. 300 Frank |
|
| May 9, 2018 |
PAHC / Phibro Animal Health Corporation / VANGUARD GROUP INC Passive Investment phibroanimalhealthcorp.htm - Generated by SEC Publisher for SEC Filing SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 4 )* Name of issuer: Phibro Animal Health Corp Title of Class of Securities: Common Stock CUSIP Number: 71742Q106 Date of Event Which Requires Filing of this Statement: April 30, 2018 Check the approp |
|
| May 7, 2018 |
Entry into a Material Definitive Agreement UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): May 7, 2018 (May 7, 2018) Phibro Animal Health Corporation (EXACT NAME OF REGISTRANT AS SPECIFIED IN CHARTER) Delaware 01-36410 13-1840497 (State or other jurisdiction of incorporation) (Commission File Number) (IRS Employer Identification No. |
|
| May 7, 2018 |
EXHIBIT 10.2 PHIBRO ANIMAL HEALTH CORPORATION 2008 INCENTIVE PLAN RESTRICTED STOCK UNIT AWARD AGREEMENT THIS AGREEMENT (this “Agreement”), made as of this [ ] day of May, 2018 (the “Grant Date”), by and between Phibro Animal Health Corporation, a Delaware corporation (the “Company”), and [ ] (the “Executive”), sets forth the terms and conditions of an Award granted to the Executive under the Phibr |
